ABSTRACT

INTRODUCTION Polycystic ovary syndrome (PCOS) is a common polygenic multifactorial condition aecting a wide population. Historically, the classic combination of symptoms was rst described in 1935 by Stein and Leventhal (1), who recognized that enlarged ovaries, amenorrhea, infertility, and hirsutism could be collated together. is collection of symptoms has been widely researched and many conclusions made, yet it continues to prove to be a dicult condition to treat. PCOS is now recognized as a spectrum disorder ranging from ultrasound features of polycystic ovarian morphology (2) to anovulatory infertility. Obesity, hyperandrogenemia, and insulin resistance are all key factors that inuence the expression and symptoms of the condition (3,4).